Low-adherence to hormonal therapy among premenopausal early breast cancer patients
“At one year from initiation of TAM, plasma measurements show that a substantial proportion of premenopausal patients are not adequately adherent to this treatment. Poorly-adherent patients could benefit from metabolic and pharmacogenetic investigations. Identification of [more]
